Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. Mthergin
2. Methergin
3. Methergine
4. Methylergobasin
5. Methylergometrin
6. Methylergometrine
7. Methylergometrine Maleate
8. Methylergonovine
1. Methylergometrine Maleate
2. 57432-61-8
3. Methergine
4. Erezingen
5. Methylergobasine Maleate
6. Ir84jpz1rk
7. Methylergometrine (maleate)
8. Nsc-757104
9. Methylergonovine Maleate [usp]
10. Methylergonovine Maleate (usp)
11. Methylergonovine Maleate Salt
12. Usaf Uctl-8
13. Maleic Acid, Methyl Ergonovine
14. Einecs 260-734-4
15. Unii-ir84jpz1rk
16. Ergonovine, Methyl-, Maleate (1:1)
17. Methyl Ergonovine Maleate Salt
18. Methergine Maleate
19. Methergine (tn)
20. 9,10-didehydro-n-((s)-1-(hydroxymethyl)propyl)-6-methylergoline-8beta-carboxamide Maleate (1:1) (salt)
21. Schembl239437
22. Spectrum1500404
23. Chebi:6874
24. Chembl1200843
25. Dtxsid1023283
26. Hms501b19
27. Methylergometrine Maleate (jp17)
28. Hms1920n11
29. Hms2091f22
30. Hms2096k09
31. Hms3262o10
32. Hms3414f15
33. Hms3678f15
34. Hms3713k09
35. Methylergonovinium Bimaleate
36. Pharmakon1600-01500404
37. Tox21_500794
38. Ccg-39168
39. Methylergonovine Maleate [mi]
40. Nsc757104
41. Akos024282479
42. Lp00794
43. Methylergometrine Maleate [jan]
44. Nsc 757104
45. Methylergonovine Maleate [vandf]
46. Methylergometrine Maleate [mart.]
47. Methylergonovine Maleate [usp-rs]
48. Ncgc00261479-01
49. 9,10-didehydro-n-[(s)-1-(hydroxymethyl)propyl]-6-methylergoline-8beta-carboxamide Maleate Salt
50. Ergoline-8-carboxamide, 9,10-didehydro-n-((1s)-1-(hydroxymethyl)propyl)-6-methyl-, (8beta)-, (2z)-2-butenedioate (1:1) (salt)
51. Ergoline-8-carboxamide, 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-6-methyl-, (8beta(s))-, (z)-2-butenedioate (1:1) (salt)
52. Methylergometrine Maleate [who-dd]
53. Hy-100988
54. B6347
55. Cs-0020668
56. Eu-0100794
57. Methylergonovine Maleate [orange Book]
58. D00680
59. M 2776
60. Methylergometrine Maleate [ep Monograph]
61. Methylergonovine Maleate [usp Monograph]
62. 432m618
63. N-[alpha-(hydroxymethyl)propyl]-d-lysergamide Maleate
64. Q27280864
65. Methylergometrine Maleate, European Pharmacopoeia (ep) Reference Standard
66. [8?(s)]-9,10-didehydro-n-[1-(hydroxymethyl)propyl]-6-methylergoline-8-carboxamide Maleate
67. Methylergometrine For System Suitability, European Pharmacopoeia (ep) Reference Standard
68. Methylergonovine Maleate, United States Pharmacopeia (usp) Reference Standard
69. (8beta)-9,10-didehydro-n-[(1s)-1-(hydroxymethyl)propyl]-6-methyl-ergoline-8-carbox-amide Maleate
70. 7054-07-1
71. 9,10-didehydro-n-((s)-1-(hydroxymethyl)propyl)-6-methylergoline-8.beta.-carboxamide Maleate
72. Ergoline-8-carboxamide, 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-6-methyl-, (8.beta.(s))-, (z)-2-butenedioate
Molecular Weight | 455.5 g/mol |
---|---|
Molecular Formula | C24H29N3O6 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 6 |
Exact Mass | 455.20563565 g/mol |
Monoisotopic Mass | 455.20563565 g/mol |
Topological Polar Surface Area | 143 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 668 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Methergine |
Drug Label | Methergine(methylergonovine maleate) is a semi-synthetic ergot alkaloid used for the prevention and controlof postpartum hemorrhage.Methergine is available in sterile ampuls of 1 mL, containing 0.2mg methylergonovine maleate for intramuscular... |
Active Ingredient | Methylergonovine maleate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 0.2mg/ml; 0.2mg |
Market Status | Prescription |
Company | Edison Theraps |
2 of 4 | |
---|---|
Drug Name | Methylergonovine maleate |
PubMed Health | Methylergonovine (Injection) |
Drug Classes | Uterine Stimulant |
Drug Label | Methylergonovine Maleate is a semi-synthetic ergot alkaloid used for the prevention and control of postpartum hemorrhage.Methylergonovine Maleate Tablets, USP is available in tablets for oral ingestion containing 0.2 mg methylergonovine maleate.... |
Active Ingredient | Methylergonovine maleate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 0.2mg/ml; 0.2mg |
Market Status | Prescription |
Company | Novel Labs; Ergoject; Luitpold |
3 of 4 | |
---|---|
Drug Name | Methergine |
Drug Label | Methergine(methylergonovine maleate) is a semi-synthetic ergot alkaloid used for the prevention and controlof postpartum hemorrhage.Methergine is available in sterile ampuls of 1 mL, containing 0.2mg methylergonovine maleate for intramuscular... |
Active Ingredient | Methylergonovine maleate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 0.2mg/ml; 0.2mg |
Market Status | Prescription |
Company | Edison Theraps |
4 of 4 | |
---|---|
Drug Name | Methylergonovine maleate |
PubMed Health | Methylergonovine (Injection) |
Drug Classes | Uterine Stimulant |
Drug Label | Methylergonovine Maleate is a semi-synthetic ergot alkaloid used for the prevention and control of postpartum hemorrhage.Methylergonovine Maleate Tablets, USP is available in tablets for oral ingestion containing 0.2 mg methylergonovine maleate.... |
Active Ingredient | Methylergonovine maleate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 0.2mg/ml; 0.2mg |
Market Status | Prescription |
Company | Novel Labs; Ergoject; Luitpold |
Oxytocics
Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Methylergonovine Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methylergonovine Maleate, including repackagers and relabelers. The FDA regulates Methylergonovine Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methylergonovine Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methylergonovine Maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Methylergonovine Maleate supplier is an individual or a company that provides Methylergonovine Maleate active pharmaceutical ingredient (API) or Methylergonovine Maleate finished formulations upon request. The Methylergonovine Maleate suppliers may include Methylergonovine Maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Methylergonovine Maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Methylergonovine Maleate DMF (Drug Master File) is a document detailing the whole manufacturing process of Methylergonovine Maleate active pharmaceutical ingredient (API) in detail. Different forms of Methylergonovine Maleate DMFs exist exist since differing nations have different regulations, such as Methylergonovine Maleate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Methylergonovine Maleate DMF submitted to regulatory agencies in the US is known as a USDMF. Methylergonovine Maleate USDMF includes data on Methylergonovine Maleate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Methylergonovine Maleate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Methylergonovine Maleate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Methylergonovine Maleate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Methylergonovine Maleate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Methylergonovine Maleate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Methylergonovine Maleate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Methylergonovine Maleate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Methylergonovine Maleate suppliers with NDC on PharmaCompass.
Methylergonovine Maleate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methylergonovine Maleate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methylergonovine Maleate GMP manufacturer or Methylergonovine Maleate GMP API supplier for your needs.
A Methylergonovine Maleate CoA (Certificate of Analysis) is a formal document that attests to Methylergonovine Maleate's compliance with Methylergonovine Maleate specifications and serves as a tool for batch-level quality control.
Methylergonovine Maleate CoA mostly includes findings from lab analyses of a specific batch. For each Methylergonovine Maleate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methylergonovine Maleate may be tested according to a variety of international standards, such as European Pharmacopoeia (Methylergonovine Maleate EP), Methylergonovine Maleate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methylergonovine Maleate USP).
LOOKING FOR A SUPPLIER?